B CELL HYPERFUNCTION AFTER LONG-TERM SULFONYLUREA TREATMENT.
D000818:Animals; D001402:B-Lymphocytes; D001786:Blood Glucose; D004583:Electrons; D006056:Golgi Apparatus; D007004:Hypoglycemic Agents; D062312:Islands; D007515:Islets of Langerhans; D008247:Lysosomes; D008853:Microscopy; D008854:Microscopy, Electron; D010336:Pathology; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012270:Ribosomes; D013453:Sulfonylurea Compounds; D014042:Tolazamide
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014042:Tolazamide
ANTIDIABETICS; BLOOD SUGAR; EXPERIMENTAL LAB STUDY; GOLGI APPARATUS; ISLANDS OF LANGERHANS; LYSOSOMES; MICROSCOPY, ELECTRON; PATHOLOGY; PHARMACOLOGY; RABBITS; RIBOSOMES; TOLAZAMIDE